The National Agency for Medicines and Health Products in Tunisia has established an official system that allows citizens and healthcare professionals to report suspected counterfeit or substandard health products. This initiative aims to enhance market surveillance and protect public health. The system is open to everyone, including patients, consumers, and healthcare professionals, who are encouraged to report any doubts about the authenticity, quality, or safety of a medicine or health product.
The agency has identified several indicators that may justify a report, including unusual packaging, abnormal product appearance, or unexpected side effects after use. Additionally, products sold outside official channels or at abnormally low prices should raise concerns. The agency categorizes non-compliant products into two main groups: those that do not meet technical specifications or quality requirements, and those that are falsified, including counterfeit medicines or products with false or misleading information.
To facilitate reporting, the National Agency for Medicines and Health Products provides three channels: an online platform with an electronic form, an email address, and a physical submission option at the Ministry of Health's order office. When making a report, individuals are encouraged to provide as much information as possible about the product, including its name, dosage, batch number, expiration date, and any problems encountered.
The agency ensures that the identity of those making reports remains confidential, and submitted data is protected. Reports can be made anonymously. By launching this system, the agency is calling on citizens and healthcare professionals to be more vigilant and provide information that can help its teams intervene quickly to remove non-compliant batches from the market and issue alerts to protect public health.
The introduction of this system is part of a broader effort to strengthen the regulation of health products in Tunisia. The country has been working to improve its healthcare system and protect its population from counterfeit and substandard medicines. The National Agency for Medicines and Health Products plays a crucial role in this process, and its new reporting system is expected to contribute significantly to these efforts.
Counterfeit and substandard medicines pose a significant risk to public health, as they can be ineffective or even toxic. In many countries, including Tunisia, the sale of such products is a common problem that affects not only individuals but also the overall healthcare system. By engaging citizens and healthcare professionals in the reporting process, the agency aims to gather more information about these products and take effective action against their distribution.
The National Agency for Medicines and Health Products' new system is a positive step towards enhancing the safety and quality of health products in Tunisia. By providing a simple and confidential reporting mechanism, the agency is empowering citizens and healthcare professionals to contribute to the protection of public health. The success of this system will depend on the level of engagement from the public and healthcare professionals.
Key points
- The National Agency for Medicines and Health Products in Tunisia has launched a system for reporting suspected counterfeit or substandard health products.
- The system provides three channels for reporting: an online platform, email, and physical submission.
- The identity of those making reports remains confidential, and submitted data is protected.
